Other
Financing — other
Vertex Pharmaceuticals Financing — other decreased by 136.4% to -$400.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.0%, from -$500.00K to -$400.00K. Over 4 years (FY 2021 to FY 2025), Financing — other shows a downward trend with a -10.2% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2016
Last reportedQ1 2026May 5, 2026
How to read this metric
Large fluctuations may indicate one-time financing adjustments or changes in cash management strategies that require further investigation.
Detailed definition
Net cash flows resulting from miscellaneous financing activities that do not fall under debt issuance, equity issuance,...
Peer comparison
Highly variable across companies depending on their specific accounting for miscellaneous financing items.
Metric ID:
other_proceeds_from_payments_for_other_financing_activitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.60M | $1.40M | $1.40M | $1.30M | $400.00K | $700.00K | $1.10M | $450.00K | $450.00K | $450.00K | $450.00K | $3.50M | $900.00K | $900.00K | $900.00K | -$500.00K | $2.00M | $1.10M | $1.10M | -$400.00K |
| QoQ Change | — | -12.5% | +0.0% | -7.1% | -69.2% | +75.0% | +57.1% | -59.1% | +0.0% | +0.0% | +0.0% | +677.8% | -74.3% | +0.0% | +0.0% | -155.6% | +500.0% | -45.0% | +0.0% | -136.4% |
| YoY Change | — | — | — | — | -75.0% | -50.0% | -21.4% | -65.4% | +12.5% | -35.7% | -59.1% | +677.8% | +100.0% | +100.0% | +100.0% | -114.3% | +122.2% | +22.2% | +22.2% | +20.0% |
Range-$500.00K – $3.50M
CAGR-25.3%
Avg YoY Growth+47.3%
Median YoY Growth+16.3%
Financing — other at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's financing — other?
- Vertex Pharmaceuticals (VRTX) reported financing — other of -$400.00K in Q1 2026.
- How has Vertex Pharmaceuticals's financing — other changed year-over-year?
- Vertex Pharmaceuticals's financing — other increased by 20.0% year-over-year, from -$500.00K to -$400.00K.
- What is the long-term trend for Vertex Pharmaceuticals's financing — other?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's financing — other has grown at a -10.2% compound annual growth rate (CAGR), from $5.70M to $3.70M.
- What does financing — other mean?
- Net cash movement from non-standard financing activities.